Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by carduon Jan 17, 2011 5:39pm

261 Views

Post# 17986152

RE: UD2MD Series Post 1b - Comments on Ugly Duckli

"Having my style described by grodin as pedantic required me to look up the definition at https://www.merriam-webster.com/. Pedantic is a fair description but I draw the line at pedestrian."

Try looking up the term "paranoia"- a mental disorder characterized by systematized delusions.

BTW, I've been very busy lately involved in Machiavellian activities with my Calgarian Investment club, even though I live in Ontario.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row